Get the Stockscreener App
22.49
0.09%
-0.02
After Hours:
22.49
Fulgent Genetics Inc stock is traded at $22.49, with a volume of 191.60K.
It is down -0.09% in the last 24 hours and up +2.79% over the past month.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
See More
Previous Close:
$22.51
Open:
$22.63
24h Volume:
191.60K
Relative Volume:
0.73
Market Cap:
$688.40M
Revenue:
$290.71M
Net Income/Loss:
$-163.43M
P/E Ratio:
-4.104
EPS:
-5.48
Net Cash Flow:
$11.70M
1W Performance:
-2.26%
1M Performance:
+2.79%
6M Performance:
+18.37%
1Y Performance:
+13.36%
1-Day Range:
$22.36
$22.86
1-Week Range:
$22.09
$23.30
52-Week Range:
$14.76
$23.57
Fulgent Genetics Inc Stock (FLGT) Company Profile
Name
Fulgent Genetics Inc
Sector
Industry
Phone
626-350-0537
Address
4399 SANTA ANITA AVE, EL MONTE
Compare FLGT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
22.49 | 689.01M | 290.71M | -163.43M | 11.70M | -5.48 |
|
TMO
Thermo Fisher Scientific Inc
|
524.58 | 198.17B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
205.14 | 144.97B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
633.32 | 49.29B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
138.23 | 38.73B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
203.77 | 33.69B | 15.70B | 1.24B | 2.01B | 6.9036 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-05-25 | Upgrade | UBS | Neutral → Buy |
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-08-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-18-22 | Initiated | Raymond James | Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Feb-04-22 | Resumed | Piper Sandler | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Underperform |
| Jan-08-21 | Downgrade | Credit Suisse | Neutral → Underperform |
| Nov-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-20-20 | Initiated | Oppenheimer | Outperform |
| May-29-20 | Initiated | BTIG Research | Buy |
| Nov-05-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Mar-01-18 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Nov-07-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
View All
Fulgent Genetics Inc Stock (FLGT) Latest News
How institutional ownership impacts Fulgent Genetics Inc. stockQuarterly Profit Report & Free Real-Time Volume Trigger Notifications - newser.com
Is Fulgent Genetics Inc. stock a contrarian buy2025 Breakouts & Breakdowns & Free Expert Verified Stock Movement Alerts - newser.com
Can Fulgent Genetics Inc. stock resist sector downturnsQuarterly Market Review & Community Consensus Trade Signals - newser.com
Sentiment analysis tools applied to Fulgent Genetics Inc.Quarterly Profit Report & Daily Profit Focused Screening - newser.com
How to integrate Fulgent Genetics Inc. into portfolio analysis toolsWeekly Profit Summary & Fast Exit and Entry Strategy Plans - newser.com
Will Fulgent Genetics Inc. rebound enough to break evenJuly 2025 Highlights & Consistent Growth Equity Picks - newser.com
What dividend safety score for Fulgent Genetics Inc. stockJuly 2025 Levels & Verified Chart Pattern Signals - newser.com
Institutional scanner results for Fulgent Genetics Inc.Quarterly Market Summary & Risk Controlled Daily Trade Plans - newser.com
Is Fulgent Genetics Inc. stock a safe haven assetSell Signal & Safe Entry Point Identification - newser.com
Market reaction to Fulgent Genetics Inc.’s recent newsJuly 2025 EndofMonth & Real-Time Stock Movement Alerts - newser.com
Fulgent Genetics (NASDAQ:FLGT) Earns “Sell (D-)” Rating from Weiss Ratings - Defense World
Signaturefd LLC Has $38,000 Holdings in Fulgent Genetics, Inc. $FLGT - Defense World
What to do if you’re stuck in Fulgent Genetics Inc.July 2025 Catalysts & Fast Gaining Stock Strategy Reports - newser.com
Is Fulgent Genetics Inc. trending in predictive chart models2025 Growth vs Value & Weekly Watchlist for Hot Stocks - newser.com
How hedge fund analytics apply to Fulgent Genetics Inc. stockJuly 2025 Pullbacks & Short-Term Swing Trade Alerts - newser.com
Quantitative breakdown of Fulgent Genetics Inc. recent moveQuarterly Earnings Summary & Long-Term Capital Growth Strategies - newser.com
Can machine learning forecast Fulgent Genetics Inc. recovery2025 EndofYear Setup & Free High Return Stock Watch Alerts - newser.com
Fulgent Genetics Hits New 52-Week High at $23.57 - Markets Mojo
Why Fulgent Genetics Inc. (7F0) stock is favored by hedge fundsQuarterly Trade Report & Daily Stock Trend Reports - newser.com
Why Fulgent Genetics Inc. stock is trending among retail tradersEntry Point & Real-Time Buy Signal Alerts - newser.com
What analysts say about Fulgent Genetics Inc 7F0 stockStock Price Forecasts & Follow Top Performers in the Community - earlytimes.in
Is Fulgent Genetics Inc. stock cheap at current valuationWeekly Earnings Recap & Technical Entry and Exit Alerts - newser.com
Fulgent Genetics (NASDAQ:FLGT) Sets New 12-Month HighHere's Why - MarketBeat
Is Fulgent Genetics Inc. stock attractive for retirement portfoliosJuly 2025 News Drivers & Reliable Volume Spike Alerts - newser.com
Critical Contrast: CVR Medical (OTCMKTS:CRRVF) & Fulgent Genetics (NASDAQ:FLGT) - Defense World
What drives Fulgent Genetics Inc stock priceIndustrial Stocks Review & Small Capital Investment Tips - Early Times
Fulgent Genetics, Inc. $FLGT Shares Sold by Rhumbline Advisers - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Hits New 12-Month HighStill a Buy? - MarketBeat
Fulgent Genetics Inc Stock (FLGT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.61%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):